Prof Dr H.J.M. Smeets

Pasturino, F., De Wert, G. M. W. R., Herbrand, C., & Smeets, H. J. M. (2026). From disease prevention to fertility treatment: rethinking the use of mitochondrial donation for oocyte-related infertility in the light of safety and efficacy. Human Reproduction, 41(4), 483-487. https://doi.org/10.1093/humrep/deag027

Vallbona-Garcia, A., Tribble, J. R., Gustavsson, S. T., Benedikter, B. J., Lindsey, P. J., Webers, C. A. B., Smeets, H. J. M., Johannesson, G., Gorgels, T. G. M. F., & Williams, P. A. (2026). Short-term high-dose nicotinamide treatment across glaucoma subtypes reveals increased mtDNA content and minimal metabolomic change in blood. Experimental Eye Research, 263, Article 110807. https://doi.org/10.1016/j.exer.2025.110807

Ahmadian, S., Lindsey, P. J., Ummelen, M., Hopman, A., Van Zandvoort, M. A. M. J., Smeets, H. J. M., & Van Tienen, F. H. J. (2026). Fusion Between Control Mesoangioblasts and mtDNA-Mutant Myotubes Preserves Myotube Morphology and Mitochondrial Network Organization. International Journal of Molecular Sciences, 27(3), Article 1357. https://doi.org/10.3390/ijms27031357

Vallbona-Garcia, A., Gustavsson, S. T., Gorgels, T. G. M. F., Tribble, J. R., Webers, C. A. B., Smeets, H. J. M., Johannesson, G., Williams, P. A., & Benedikter, B. J. (2026). Circulating eNAMPT in Glaucoma: A Semi-Quantitative Plasma Analysis Before and After Nicotinamide Supplementation. Translational Vision Science & Technology, 15(1), Article 37. https://doi.org/10.1167/tvst.15.1.37

Guan, Z., Lindsey, P., Kamps, R., & Smeets, H. J. M. (2025). A bioinformatics pipeline for identifying homoplasmic and heteroplasmic mitochondrial DNA SNVs in single-cell RNA-Seq datasets. Genomics, 117(6), Article 111122. https://doi.org/10.1016/j.ygeno.2025.111122

van Tienen, F. H. J., Hoeijmakers, J. G. J., van der Leij, C., Timmer, E., Wanders, N., Lindsey, P. J., Yi, F., Lin, F., Kortekaas, S. P. M., Roelofs, H., Westra, I. M., Meij, P., Wijnen, L. A. C. M., de Coo, I. F. M., & Smeets, H. J. M. (2025). Intra-arterial transplantation of autologous mesoangioblasts in m.3243A>G mutation carriers is safe: First phase 1/2 human clinical study. Molecular Therapy, 33(10), 5061-5072. https://doi.org/10.1016/j.ymthe.2025.07.005

Kamps, R., Martens, H., de Koning, B., Smeets, B., & van Geel, M. (2025). Identifying a Novel Causal FAM83H Variant for Autosomal Dominant Amelogenesis Imperfecta Using Exome-Sequencing. Molecular genetics & genomic medicine, 13(6), Article e70108. https://doi.org/10.1002/mgg3.70108

Mertens, J., Belva, F., van Montfoort, A. P. A., Regin, M., Zambelli, F., Seneca, S., de Deckersberg, E. C., Bonduelle, M., Tournaye, H., Stouffs, K., Barbe, K., Smeets, H. J. M., van de Velde, H., Sermon, K., Blockeel, C., & Spits, C. (2025). Children Born After Assisted Reproduction More Commonly Carry a Mitochondrial Genotype Associating With Low Birthweight. Obstetrical & Gynecological Survey, 80(1), 32-33. https://doi.org/10.1097/OGX.0000000000001365

de Laat, E. C. M., Houwen-van Opstal, S. L. S., Bouman, K., van Doorn, J. L. M., Cameron, D., van Alfen, N., Dittrich, A. T. M., Kamsteeg, E. J., Smeets, H. J. M., Groothuis, J. T., Erasmus, C. E., & Voermans, N. C. (2024). Correction: A 5-year natural history study in LAMA2-related muscular dystrophy and SELENON-related myopathy: the Extended LAST STRONG study (BMC neurology (2024) 24 1 DOI: 10.1186/s12883-024-03852-4). BMC Neurology, 24(1), Article 477. https://doi.org/10.1186/s12883-024-03994-5

de Laat, E. C. M., Houwen-van Opstal, S. L. S., Bouman, K., van Doorn, J. L. M., Cameron, D., van Alfen, N., Dittrich, A. T. M., Kamsteeg, E. J., Smeets, H. J. M., Groothuis, J. T., Erasmus, C. E., Voermans, N. C., & Voermans, N. C. (2024). A 5-year natural history study in LAMA2-related muscular dystrophy and SELENON-related myopathy: the Extended LAST STRONG study. BMC Neurology, 24(1), Article 409. https://doi.org/10.1186/s12883-024-03852-4